Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 47851-47900 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05493267
A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB
PHASE4Recruiting
30 participants
Started: Aug 3, 2022 · Completed: Aug 3, 2027
2 conditions4 sponsors2 locations
NCT05507411
Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC
PHASE2Recruiting
100 participants
Started: Aug 3, 2022 · Completed: Apr 30, 2027
1 condition2 sponsors3 locations
NCT05305911
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
PHASE2Recruiting
81 participants
Started: Aug 3, 2022 · Completed: Dec 31, 2028
2 conditions1 sponsor1 location
NCT04956133
IMPACT: IMplementation of Physical Activity for Children and Adolescents on Treatment
NARecruiting
250 participants
Started: Aug 3, 2022 · Completed: Jun 1, 2028
2 conditions5 sponsors2 locations
NCT05410145
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
PHASE1/PHASE2Recruiting
442 participants
Started: Aug 3, 2022 · Completed: Feb 28, 2027
1 condition1 sponsor49 locations
NCT05444088
Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma
PHASE1/PHASE2Recruiting
129 participants
Started: Aug 2, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05454358
Letrozole as Maintenance Therapy for Post-surgical Endometrial Cancer Patients With NSMP
PHASE2/PHASE3Recruiting
299 participants
Started: Aug 2, 2022 · Completed: Jul 9, 2030
1 condition2 sponsors1 location
NCT05198661
Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection
NARecruiting
3,500 participants
Started: Aug 2, 2022 · Completed: Aug 2, 2032
1 condition1 sponsor62 locations
NCT05287399
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors
PHASE1Recruiting
16 participants
Started: Aug 2, 2022 · Completed: Dec 20, 2024
1 condition2 sponsors4 locations
NCT05926804
"A Screen and Treat Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile"
NARecruiting
500 participants
Started: Aug 2, 2022 · Completed: Mar 31, 2027
1 condition2 sponsors3 locations
NCT04743245
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
NARecruiting
434 participants
Started: Aug 2, 2022 · Completed: Apr 30, 2026
2 conditions1 sponsor1 location
NCT05385367
Life Cycle Assessment of Different Types of Anesthetic
NARecruiting
90 participants
Started: Aug 2, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT05491980
Florida Cerebrovascular Disease Biorepository and Genomics Center
N/ARecruiting
5,000 participants
Started: Aug 2, 2022 · Completed: Oct 31, 2025
19 conditions1 sponsor1 location
NCT05047172
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
PHASE3Recruiting
1,683 participants
Started: Aug 2, 2022 · Completed: May 31, 2028
2 conditions6 sponsors129 locations
NCT06334471
Whole Genome Sequencing in Breast Cancer
N/ARecruiting
1,200 participants
Started: Aug 2, 2022 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT05092347
A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)
PHASE1/PHASE2Recruiting
56 participants
Started: Aug 2, 2022 · Completed: Dec 12, 2026
1 condition1 sponsor10 locations
NCT05111561
Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer
PHASE1Recruiting
42 participants
Started: Aug 2, 2022 · Completed: Mar 14, 2027
5 conditions1 sponsor4 locations
NCT05291507
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System
EARLY_PHASE1Recruiting
34 participants
Started: Aug 2, 2022 · Completed: Aug 1, 2027
1 condition1 sponsor1 location
NCT05477563
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
PHASE3Recruiting
26 participants
Started: Aug 2, 2022 · Completed: Jun 9, 2027
7 conditions1 sponsor6 locations
NCT05556902
Therapeutic Mechanisms of Epidural Spinal Cord Stimulation
NARecruiting
80 participants
Started: Aug 2, 2022 · Completed: May 1, 2030
3 conditions1 sponsor1 location
NCT06329453
Intestinal Immunity in Neurologic Disease
N/ARecruiting
100 participants
Started: Aug 2, 2022 · Completed: Aug 31, 2027
3 conditions1 sponsor1 location
NCT05432349
Rett Syndrome Registry
N/ARecruiting
3,000 participants
Started: Aug 2, 2022 · Completed: Jul 31, 2028
10 conditions16 sponsors18 locations
NCT05815329
MASCoD - Multidimensional Assessment of Subjective Cognitive Decline
NARecruiting
100 participants
Started: Aug 2, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05388890
Treatment of Atrophic Gastritis After HP Eradication With Modified Liujunzi Decoction Based on Syndrome Differentiation
N/ARecruiting
286 participants
Started: Aug 2, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06343103
Study Evaluating Occupational Exposure to Antineoplastic Drugs
NARecruiting
500 participants
Started: Aug 2, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor5 locations
NCT05467800
Study of Canakinumab in Patients With Myelofibrosis
PHASE2Recruiting
14 participants
Started: Aug 2, 2022 · Completed: Jul 1, 2027
5 conditions1 sponsor8 locations
NCT05637099
The Value of Repeated BIOMarker Measurements During an SBT to Predict EXtubation Failure in ICU Patients
N/ARecruiting
266 participants
Started: Aug 1, 2022 · Completed: Jun 1, 2026
4 conditions2 sponsors1 location
NCT06075693
Cerebrospinal Fluid Biomarkers of Myotonic Dystrophy
N/ARecruiting
88 participants
Started: Aug 1, 2022 · Completed: Aug 1, 2028
1 condition1 sponsor1 location
NCT05537545
Timing of Soft Tissue Grafting Following Immediate Implant Placement
NARecruiting
40 participants
Started: Aug 1, 2022 · Completed: Jul 1, 2028
1 condition1 sponsor1 location
NCT06418646
Patients' and Caregivers' Views of Multidimensional Care in Amyotropic Lateral Sclerosis in Germany
N/ARecruiting
500 participants
Started: Aug 1, 2022 · Completed: Jun 30, 2025
1 condition3 sponsors1 location
NCT05480319
Prospective Deployment of a Cardiac Arrest Response System (EDICARS) in the Emergency Department
NARecruiting
2,010 participants
Started: Aug 1, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05470127
Evaluation of the Performance of a Novel Prostate Biopsy System Compared With Standard of Care Biopsy Needle on Quantitative and Qualitative Tissue Parameters
NARecruiting
200 participants
Started: Aug 1, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05444712
Transplantation After Complete Response In Patients With T-cell Lymphoma
NARecruiting
204 participants
Started: Aug 1, 2022 · Completed: Apr 1, 2028
1 condition1 sponsor48 locations
NCT05022238
Hotspots, Households and Hospitals: Enhanced Drug-resistant Tuberculosis Case Finding in Namibia
N/ARecruiting
2,100 participants
Started: Aug 1, 2022 · Completed: Sep 30, 2026
1 condition9 sponsors1 location
NCT05463107
Correlation Between Various Urinary Exosomal Protein Biomarkers and Pathological Manifestation in Thyroid Follicular Neoplasm: Early and Pre-operative Diagnosis of Follicular Thyroid Cancer
N/ARecruiting
50 participants
Started: Aug 1, 2022 · Completed: Jul 31, 2028
2 conditions1 sponsor1 location
NCT05272488
A Combined Treatment of Manual Therapy and Nervous Vagus Stimulation in Patients With Myogenic Temporomandibular Disorders
NARecruiting
60 participants
Started: Aug 1, 2022 · Completed: Sep 15, 2025
2 conditions1 sponsor3 locations
NCT05600660
Orelabrutinib,Rituximab and Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma
PHASE2Recruiting
28 participants
Started: Aug 1, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05265000
Transcutaneous Spinal Cord Stimulation for Chronic Low Back Pain
NARecruiting
50 participants
Started: Aug 1, 2022 · Completed: Jun 1, 2026
1 condition2 sponsors1 location
NCT05567627
Clinical Exploration of Adeno-associated Virus (AAV) Expressing Human Acid Alpha- Glucosidase (GAA) Gene Therapy for Patients With Infantile-onset Pompe Disease
NARecruiting
6 participants
Started: Aug 1, 2022 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05522218
Eluvia DES for the Patients with Femoropopliteal Artery Lesions.
N/ARecruiting
400 participants
Started: Aug 1, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05382520
Sensory Rehabilitation in Chemotherapy Induced Peripheral Neuropathy (CIPN)
NARecruiting
12 participants
Started: Aug 1, 2022 · Completed: Dec 1, 2025
1 condition2 sponsors1 location
NCT05192837
Preoperative Smoking Cessation in Patients Undergoing Surgery
NARecruiting
251 participants
Started: Aug 1, 2022 · Completed: Sep 30, 2029
13 conditions1 sponsor1 location
NCT04849507
BabyStrong Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) Paired Bottle Feeding to Improve Oral Feeding
PHASE1Recruiting
20 participants
Started: Aug 1, 2022 · Completed: Aug 1, 2024
1 condition2 sponsors1 location
NCT05841290
The Incidence of Postoperative Pain After Using Different Types of Sealers
NARecruiting
50 participants
Started: Aug 1, 2022 · Completed: Oct 31, 2024
4 conditions1 sponsor1 location
NCT05495399
Post Operative RT for Limited Spine Metastases
NARecruiting
111 participants
Started: Aug 1, 2022 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT05468957
Comparing Perclose to Statseal in Conjunction with Perclose in Femoral 6 French Arteriotomy Closure
NARecruiting
150 participants
Started: Aug 1, 2022 · Completed: Jul 31, 2025
4 conditions1 sponsor2 locations
NCT05606575
A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning - Nelli
N/ARecruiting
104 participants
Started: Aug 1, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05831631
Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors
N/ARecruiting
200 participants
Started: Aug 1, 2022 · Completed: Aug 1, 2029
2 conditions1 sponsor1 location
NCT05494086
Dual-Port Laparoscopic Distal Gastrectomy for Gastric Cancer
NARecruiting
300 participants
Started: Aug 1, 2022 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT05495672
Circulating Tumor DNA Guided Therapeutic Strategies for CRC Patients With Small Pulmonary Nodules
NARecruiting
100 participants
Started: Aug 1, 2022 · Completed: Dec 1, 2025
2 conditions2 sponsors1 location